New RFI's Released!


Read More

New RFI for Improved Nerve Agent Treatment System (INATS) Released


Read More

NEW! RPP-18-01 – JSTO Topics


Read More

Prevent

Prophylaxis, pretreatment, and post-exposure prophylaxis

Diagnose

Systems and devices to identify CBRN agents and assist in making medical decisions

Treat

Therapeutics for post-exposure and post-symptomatic

Welcome Newest Members

Hawaii Biotech, Inc.

Humanetics Corporation

CMC Pharmaceuticals, Inc.

Wake Forest University Health Sicences

Northern Arizona University

ADS, Inc.


View All Members
Upcoming Events

2017 CBD S&T Conference
Long Beach Convention Center November 28-30, 2017


See All News & Events
News and Announcements

International Participation: Membership in MCDC is limited to US companies or US-based affiliates of foreign companies. Foreign companies cannot gain membership due to MCDC’s requirement that members obtain a DD2345 (military critical technical data agreement). However, foreign companies can be subcontractors (team members) on projects awarded through the Other Transaction Agreement (OTA) as long as they can meet the terms and conditions of the OTA. The MCDC member awarded the project is responsible for flowing the applicable requirements down to the foreign company.


read more